Empress Therapeutics
+7
Mar 31, 2026
•
8 min read
Plus Addgenes' new partnership, and Neumora and Acrivon's cash flow updates
Enanta Pharmaceuticals
+16
Nov 18, 2025
Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more
Nov 11, 2025
6 min read
Talking about proteases, PROTACs, and molecular glues. Plus new methods for mass spec tagging, viral inhibitors, and more.
+12
Nov 4, 2025
Soufflé Therapeutics Launches from Stealth, Disc and Werewolf receive FDA priority, Affini-T may be winding down.
